Reshaping the enzyme market
Science with Purpose. Innovation with Impact
Local solutions for diagnostics and R&D today. Global innovation in therapeutics tomorrow.
Biotech Made Smarter: Today and Tomorrow
At NexEnzymes, we’re building a new kind of biotech company—rooted in Latin America, powered by science, and driven by purpose. Our approach is dual: we deliver high-quality enzyme products for diagnostics and molecular research while laying the groundwork for the next generation of microbiome-driven therapeutics.
We started by solving an urgent need: giving Latin American labs faster, affordable access to critical reagents like DNA polymerases and One-Step qPCR kits—locally manufactured, customizable, and compliant with global quality standards.
But we're not stopping there.
Our Vision: Scalable Science with Deep Impact
A self-sustaining biotech platform to unlock therapeutic breakthroughs.
We believe world-class biotech doesn’t need to rely endlessly on external capital. By creating a financially sustainable diagnostics business in the short term, we’re funding the next frontier: developing cyclic peptides that modulate enzymes of the microbiome, enhancing drug efficacy and enabling new pharma strategies.
We're currently advancing partnerships with global players to co-develop peptide therapeutics targeting obesity, diabetes, and other metabolic conditions.
Our long-term mission is bold but clear:
Make diagnostics accessible. Make therapeutics smarter. Build it all from Latin America.
Our Product Pipeline
Diagnostic and R&D Products
Products:
NexPCR
NexFidelity
NexRT
NexqPCR One-Step Probe
NexqPCR One-Step Green
NexqPCR Probe
Applications:
End-Point PCR, TA-cloning
Cloning, Sequencing
cDNA for RT-PCR and Libraries
qRT-PCR for multiplex probes RNA Targets
qRT-PCR for SYBR Green single RNA Target
qPCR for multiplex DNA target
Pharma & Peptide Therapeutics Pipeline
How We Work
Tech meets purpose.
We combine protein engineering, precision fermentation, and AI-driven bioinformatics to develop products for two key markets:
Diagnostics & R&D:
Local production of off-patent enzymes, develop our own formulation to produce enzyme-based products ready to use in Master mix formato with high industrial quality, short delivery times, and custom formulations.
Pharma & Peptide Therapeutics:
An AI-guided pipeline to identify microbiome-related therapeutic targets, design cyclic peptides in silico, and validate in vitro/in vivo.
This integrated platform allows us to innovate quickly, scale efficiently, and collaborate deeply with researchers and pharmaceutical partners.
Our Team
Scientists. Builders. LATAM biotech believers.
CEO & Co-Founder
Bernardo Collao PhD
Biochemist, Master in biochemistry adn a PhD in Molecular Bioscience, with +17 years leading protein engineering teams, managing R&D budgets above USD 3M/year, and optimizing production pipelines to improve quality and reduce costs. He has founded, directed, and advised multiple biotech companies in LATAM.
CSO & Co-Founder
Daniel Almonacid PhD
Biochemist and PhD in Molecular Informatics (Cambridge, UCSF), is a top global patent holder in the microbiome field with over 500 patents. He has led R&D teams of 100+ PhDs across the U.S. and Chile and raised more than USD 4M from pre-seed to Series C rounds. He has founded and held CxO and VP positions, aldo advised several biotech companies globally.
Partners
Customers
